Azenta Beats Q4 Estimates, Stock Now 20% Above New Analyst Target

NEW YORK, November 12 —

Azenta, Inc. (AZTA) beat Q4 2026 earnings estimates and ended Wednesday at $48.9, some 20% above the analyst price target raised in response to the results.

21% Short Float Poured Fuel on the Move

Going into the print, 21.7% of Azenta's float was sold short. That level turns any positive surprise into a mechanically amplified rally, short sellers covering positions don't pause to weigh valuation; they buy to exit. The spike visible in the chart on Wednesday reflects both a genuine fundamental re-rating and forced covering pressure, and separating the two matters when sizing a new position at $48.9. At that price, any guidance stumble will not unwind in an orderly fashion.

$106 Million FCF Tells a Different Story Than -$2.47 EPS

A trailing EPS of -$2.47 looks like a company in distress. Azenta generated $106mn in free cash flow on $622mn in TTM revenue, a 17% FCF margin that most cash-generating industrials would not refuse. The gap almost certainly reflects acquisition-related amortization dragging the GAAP income statement below cash reality, a structure typical of life sciences tools businesses that consolidated through several deal cycles.

Revenue is growing 5.1% YoY. The cash is real. The question is whether GAAP earnings can close the gap to cash earnings fast enough to justify a 71.1x forward multiple.

Analysts Raised Their Target to $40.2 and the Stock Blew Past It the Same Day

The consensus 12-month target, freshly raised to $40.2, now sits roughly 18% below where the stock is trading. That gap is not a rounding error, it means analysts are modeling a recovery while the market is pricing a re-rating. One of them is wrong. At 71.1x fwd P/E with negative trailing earnings, the burden of proof falls on the stock price, not the analyst model.

The contrarian read worth holding: the wire story credits the beat. What it underweights is that AZTA's FCF yield against $622mn in revenue already implies a structurally profitable core business obscured by non-cash drag. If that drag rolls off faster than analysts expect, the gap closes from both directions.

Q1 2027 Operating Margin Is the Number That Changes Everything

Guidance and operating margin for Q1 2027 from the earnings call are the two figures that separate a sustainable re-rating from a short-squeeze artifact. Specifically: if operating margin moves toward positive territory, that multiple has a credible path. If guidance disappoints, the 18% spread between price and consensus target closes quickly, and with 21.7% of the float still potentially exposed, that unwind would be disorderly. Write down Q1 2027 operating margin. That is the number that proves or breaks this setup.

To stress-test the revenue growth and margin assumptions behind that entry price on Azenta, the DCF calculator lets you model the earnings inflection the market is pricing.

A full Azenta intelligence profile, historical margin progression, valuation comparables, and coverage universe context, is available at basisreport.com/stock/azta.

Basis Report is independent research for informational purposes. It is not investment advice and not a recommendation to buy or sell any security.